These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 26993301)

  • 1. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
    Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
    Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of resveratrol in Alzheimer disease pathology.
    Rege SD; Geetha T; Griffin GD; Broderick TL; Babu JR
    Front Aging Neurosci; 2014; 6():218. PubMed ID: 25309423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease.
    Kou X; Chen N
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28837083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol as a therapeutic agent for Alzheimer's disease.
    Ma T; Tan MS; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():350516. PubMed ID: 25525597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of resveratrol in Alzheimer's disease.
    Vingtdeux V; Dreses-Werringloer U; Zhao H; Davies P; Marambaud P
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S6. PubMed ID: 19090994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcuminoids and resveratrol as anti-Alzheimer agents.
    Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):515-25. PubMed ID: 23276553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
    Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
    J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol, a neuroprotective supplement for Alzheimer's disease.
    Li F; Gong Q; Dong H; Shi J
    Curr Pharm Des; 2012; 18(1):27-33. PubMed ID: 22211686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.
    Braidy N; Jugder BE; Poljak A; Jayasena T; Mansour H; Nabavi SM; Sachdev P; Grant R
    Curr Top Med Chem; 2016; 16(17):1951-60. PubMed ID: 26845555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic.
    Misiti F; Sampaolese B; Mezzogori D; Orsini F; Pezzotti M; Giardina B; Clementi ME
    Brain Res Bull; 2006 Dec; 71(1-3):29-36. PubMed ID: 17113925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol--a boon for treating Alzheimer's disease?
    Anekonda TS
    Brain Res Rev; 2006 Sep; 52(2):316-26. PubMed ID: 16766037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.
    Copani A; Guccione S; Giurato L; Caraci F; Calafiore M; Sortino MA; Nicoletti F
    Curr Med Chem; 2008; 15(24):2420-32. PubMed ID: 18855671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
    Agostinho P; Cunha RA; Oliveira C
    Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antioxidants in Alzheimer's disease.
    Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease.
    Venigalla M; Sonego S; Gyengesi E; Sharman MJ; Münch G
    Neurochem Int; 2016 May; 95():63-74. PubMed ID: 26529297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.
    Regitz C; Fitzenberger E; Mahn FL; Dußling LM; Wenzel U
    Eur J Nutr; 2016 Mar; 55(2):741-747. PubMed ID: 25851110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective properties of resveratrol in different neurodegenerative disorders.
    Albani D; Polito L; Signorini A; Forloni G
    Biofactors; 2010; 36(5):370-6. PubMed ID: 20848560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer's disease.
    Wang H; Jiang T; Li W; Gao N; Zhang T
    Toxicol Lett; 2018 Jan; 282():100-108. PubMed ID: 29097221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol: A Focus on Several Neurodegenerative Diseases.
    Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
    Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.